Yezaz Ghouri

Credentials: · · · · ·

History

Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis
Review · Journal of Carcinogenesis · 2017 · First of 3 authors · 558 citations
Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease
Review · Clinical and Experimental Gastroenterology · 2014 · First of 6 authors · 221 citations
Cancer review: Cholangiocarcinoma
Review · Journal of Carcinogenesis · 2015 · First of 3 authors · 124 citations

Variability in Microbial Response to Dietary Fiber
Principal investigator · Completed
University of Missouri-Columbia
2022–2023
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Site PI · Recruiting · Phase 4
Takeda
2025–2028
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Site PI · Recruiting · Phase 2
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
2024–2030